Yu-Ying Chang Selected Research

monascin

1/2015	Monascus secondary metabolites monascin and ankaflavin inhibit activation of RBL-2H3 cells.
11/2013	A novel natural Nrf2 activator with PPARγ-agonist (monascin) attenuates the toxicity of methylglyoxal and hyperglycemia.
2/2013	Effects of monascin on anti-inflammation mediated by Nrf2 activation in advanced glycation end product-treated THP-1 monocytes and methylglyoxal-treated wistar rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu-Ying Chang Research Topics

Disease

4	Neoplasms (Cancer) 08/2018 - 06/2012
3	Hyperglycemia 11/2013 - 12/2012
2	Insulin Resistance 11/2013 - 12/2012
2	Type 2 Diabetes Mellitus (MODY) 11/2013 - 02/2013
2	Inflammation (Inflammations) 02/2013 - 12/2012
1	COVID-19 01/2022
1	Neoplasm Metastasis (Metastasis) 08/2018
1	Hepatocellular Carcinoma (Hepatoma) 08/2018
1	Leukemia 01/2016
1	Nijmegen Breakage Syndrome 07/2015
1	Infections 07/2015
1	Genomic Instability 07/2015
1	Hypersensitivity (Allergy) 01/2015
1	Asthma (Bronchial Asthma) 01/2015
1	Malignant Mesothelioma 01/2015
1	Myopia 08/2014
1	Edema (Dropsy) 08/2014
1	Choroidal Neovascularization 08/2014
1	Breast Neoplasms (Breast Cancer) 06/2012
1	Mouth Neoplasms (Oral Cancer) 08/2011
1	Ulcerative Colitis 01/2008

Drug/Important Bio-Agent (IBA)

3	monascinIBA 01/2015 - 02/2013
3	Pyruvaldehyde (Methylglyoxal)IBA 11/2013 - 12/2012
2	ankaflavinIBA 01/2015 - 12/2012
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2013 - 12/2012
2	Advanced Glycation End ProductsIBA 02/2013 - 12/2012
1	AntibodiesIBA 01/2022
1	AutoantibodiesIBA 01/2022
1	Messenger RNA (mRNA)IBA 08/2018
1	NIMA-Related KinasesIBA 08/2018
1	Cadherins (E-Cadherin)IBA 08/2018
1	Biomarkers (Surrogate Marker)IBA 08/2018
1	RNA (Ribonucleic Acid)IBA 01/2016
1	QuercetinIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	FlavonoidsIBA 01/2016
1	HSP27 Heat-Shock ProteinsIBA 01/2016
1	Oncogene Proteins (Oncogene Protein)IBA 07/2015
1	Karyopherins (Importin)IBA 07/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2015
1	DNA (Deoxyribonucleic Acid)IBA 07/2015
1	OvalbuminIBA 01/2015
1	AsbestosIBA 01/2015
1	Bevacizumab (Avastin)FDA Link 08/2014
1	Rosiglitazone (Avandia)FDA Link 11/2013
1	Receptor for Advanced Glycation End ProductsIBA 02/2013
1	LigandsIBA 02/2013
1	Insulin (Novolin)FDA Link 12/2012
1	CarbohydratesIBA 12/2012
1	Blood Glucose (Blood Sugar)IBA 12/2012
1	AntioxidantsIBA 12/2012
1	Glucose (Dextrose)FDA LinkGeneric 12/2012
1	Aldehyde DehydrogenaseIBA 06/2012
1	Adenosine Triphosphate (ATP)IBA 06/2012
1	geldanamycinIBA 06/2012
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2012
1	arseniteIBA 08/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2008

Therapy/Procedure

1	Injections 08/2014
1	Oral Administration 11/2013
1	Aftercare (After-Treatment) 02/2013
1	Therapeutics 06/2012